- Terveys ja hyvinvointi
- Tapahtumapäivämäärä:
-
- Aika:
- 15:00–16:00
- Tapahtumapaikka:
-
Verkossa
- Lisätietoja:
-
Zoom
- Lisää kalenteriin:
Google
Targeting the R-Spine: Design, Synthesis and Biological Evaluation of Novel Type I½ p38α MAP Kinase Inhibitors with Excellent Selectivity, High Potency and Prolonged Target Residence Time: Implication for Cancer- and CNS-Applications.
Professor Dr. Stefan A. Laufer, Head Medicinal Chemistry, Department Pharmacy & Biochemistry, Eberhard-Karls-University Tuebingen, Germany.
For further information, please contact Karin Koivisto, karin.koivisto@uef.fi.
